Circulating Tumor Cells Market (By Technology: CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis; By Application: Clinical/ Liquid Biopsy, Research; By Product: Kits & Reagents, Blood Collection Tubes, Devices or Systems; By Specimen: Blood, Bone Marrow, Other Body Fluids) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Circulating Tumor Cells Market, By Technology

7.1.  Circulating Tumor Cells Market, by Technology, 2020-2030

7.1.1.    CTC Detection & Enrichment Methods

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    CTC Direct Detection Methods

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    CTC Analysis

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Circulating Tumor Cells Market, By Application

8.1.  Circulating Tumor Cells Market, by Application, 2020-2030

8.1.1.    Clinical/ Liquid Biopsy

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Research

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Circulating Tumor Cells Market, By Product

9.1.  Circulating Tumor Cells Market, by Product, 2020-2030

9.1.1.    Kits & Reagents

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Blood Collection Tubes

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Devices or Systems

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Circulating Tumor Cells Market, By Specimen

10.1.        Circulating Tumor Cells Market, by Specimen, 2020-2030

10.1.1.  Blood

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Bone Marrow

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Other Body Fluids

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Circulating Tumor Cells Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.1.2.  Market Revenue and Forecast, by Application (2016-2030)

11.1.3.  Market Revenue and Forecast, by Product (2016-2030)

11.1.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.2.2.  Market Revenue and Forecast, by Application (2016-2030)

11.2.3.  Market Revenue and Forecast, by Product (2016-2030)

11.2.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.3.2.  Market Revenue and Forecast, by Application (2016-2030)

11.3.3.  Market Revenue and Forecast, by Product (2016-2030)

11.3.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.4.2.  Market Revenue and Forecast, by Application (2016-2030)

11.4.3.  Market Revenue and Forecast, by Product (2016-2030)

11.4.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2016-2030)

11.5.2.  Market Revenue and Forecast, by Application (2016-2030)

11.5.3.  Market Revenue and Forecast, by Product (2016-2030)

11.5.4.  Market Revenue and Forecast, by Specimen (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by Specimen (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by Specimen (2016-2030)

Chapter 12.  Company Profiles

12.1.              QIAGEN

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Bio-Techne Corporation

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Precision for Medicine

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              AVIVA Biosciences

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              BIOCEPT, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              BioCEP Ltd.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Fluxion Biosciences, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Greiner Bio One International GmbH

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Ikonisys Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Miltenyi Biotec

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           IVDiagnostics

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           BioFluidica

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Canopus Bioscience Ltd.

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Biolidics Limited

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

12.15.           Creativ MicroTech, Inc.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

12.16.           LungLife AI, Inc.

12.16.1.               Company Overview

12.16.2.               Product Offerings

12.16.3.               Financial Performance

12.16.4.               Recent Initiatives

12.17.           Epic Sciences

12.17.1.               Company Overview

12.17.2.               Product Offerings

12.17.3.               Financial Performance

12.17.4.               Recent Initiatives

12.18.           Rarecells Diagnostics

12.18.1.               Company Overview

12.18.2.               Product Offerings

12.18.3.               Financial Performance

12.18.4.               Recent Initiatives

12.19.           ScreenCell

12.19.1.               Company Overview

12.19.2.               Product Offerings

12.19.3.               Financial Performance

12.19.4.               Recent Initiatives

12.20.           Menarini Silicon Biosystems

12.20.1.               Company Overview

12.20.2.               Product Offerings

12.20.3.               Financial Performance

12.20.4.               Recent Initiatives

12.21.           LineaRx, Inc. (Vitatex, Inc.)

12.21.1.               Company Overview

12.21.2.               Product Offerings

12.21.3.               Financial Performance

12.21.4.               Recent Initiatives

12.22.           Sysmex Corporation

12.22.1.               Company Overview

12.22.2.               Product Offerings

12.22.3.               Financial Performance

12.22.4.               Recent Initiatives

12.23.           STEMCELL Technologies, Inc.

12.23.1.               Company Overview

12.23.2.               Product Offerings

12.23.3.               Financial Performance

12.23.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms